Trial
NCT01025882
Margin-Intense Combo Therapy in Pts w/Potentially Resectable Pancreatic Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Texas Southwestern Medical Center
Collaborators
—
Condition
Pancreatic Cancer
Intervention
gemcitabine hydrochloride
Why stopped
DSMC closed due to patient deaths
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-02-05